Company Overview of Agendia N.V.
Agendia N.V., a commercial-stage molecular diagnostic company, focuses on the discovery, development, marketing, and commercialization of genomic-based diagnostic products to improve the quality of life for cancer patients by providing healthcare professionals with critical information to enable personalized treatment. It offers Symphony suite of molecular diagnostic breast cancer tests, such as TargetPrint, a microarray-based gene expression assay, which offers a quantitative assessment of the patient’s level of estrogen receptor, progesterone receptor, and HER2/neu gene within breast cancer tumor; and MammaPrint, a IVDMIA gene expression breast cancer assay that provides physicians with th...
Matrix Innovation Center
Science Park 406
Amsterdam, 1098 XH
Founded in 2003
Key Executives for Agendia N.V.
Co-Founder and Chief Research Officer
Co-Founder and Chief Scientific Officer
Chief Financial Officer and Vice President of Finance
Chief Medical Officer and Member of Medical Advisory Board
Compensation as of Fiscal Year 2013.
Agendia N.V. Key Developments
Agendia N.V. Presents at 2013 Credit Suisse Annual Healthcare Conference, Nov-14-2013 08:00 AM
Oct 8 13
Agendia N.V. Presents at 2013 Credit Suisse Annual Healthcare Conference, Nov-14-2013 08:00 AM. Venue: The Phoenician, Scottsdale, Arizona, United States. Speakers: Glen M. Fredenberg, Chief Financial Officer and Vice President of Finance.
Agendia N.V. Appoints Peter W. Schineller as Chief Commercial Officer
Jun 3 13
Agendia N.V. announced the addition of Peter W. Schineller as its Chief Commercial Officer. In this newly created position, Mr. Schineller will lead Agendia's global commercialization activities as it delivers technologies to translate personalized diagnostics into actionable, patient-centered solutions for clinicians. Mr. Schineller's 25-year professional career spans both the diagnostic and pharmaceutical industry. Most recently, Mr. Schineller served as Senior Vice President and Chief Commercial Officer at Alexza Pharmaceuticals.
Agendia N.V. Presents at Canaccord Genuity 33rd Annual Growth Conference, Aug-15-2013 08:30 AM
May 27 13
Agendia N.V. Presents at Canaccord Genuity 33rd Annual Growth Conference, Aug-15-2013 08:30 AM. Venue: InterContinental Boston, 520 Atlantic Avenue, Boston, MA 02110, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|